Ritesh Gupta
Overview
Explore the profile of Ritesh Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Singh A, Gupta R, Misra A
Diabetes Metab Syndr
. 2020 Jun;
14(5):729.
PMID: 32473904
No abstract available.
12.
Ghosh A, Dutta K, Tyagi K, Gupta R, Misra A
Diabetes Metab Syndr
. 2020 May;
14(4):577-578.
PMID: 32416526
No abstract available.
13.
Gupta R, Hussain A, Misra A
Eur J Clin Nutr
. 2020 May;
74(6):864-870.
PMID: 32404898
Patients with diabetes who get coronavirus disease 2019 (COVID-19) are at risk of a severe disease course and mortality. Several factors especially the impaired immune response, heightened inflammatory response and...
14.
15.
Singh A, Gupta R, Ghosh A, Misra A
Diabetes Metab Syndr
. 2020 Apr;
14(4):303-310.
PMID: 32298981
Background And Aims: High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and...
16.
Singh A, Gupta R, Misra A
Diabetes Metab Syndr
. 2020 Apr;
14(4):283-287.
PMID: 32283499
Background And Aims: COVID-19 is already a pandemic. Emerging data suggest an increased association and a heightened mortality in patients of COVID-19 with comorbidities. We aimed to evaluate the outcome...
17.
Ghosh A, Gupta R, Misra A
Diabetes Metab Syndr
. 2020 Apr;
14(4):273-276.
PMID: 32283497
Background And Aims: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario....
18.
Gupta R, Misra A
Diabetes Metab Syndr
. 2020 Apr;
14(3):251-254.
PMID: 32247213
Background And Aims: Multiple issues in management of COVID have emerged, but confusion persists regarding rational interpretation. Aim of this brief review is to review these issues based on current...
19.
Gupta R, Gupta A, Shrikhande M, Tyagi K, Ghosh A, Misra A
Diabetes Res Clin Pract
. 2020 Apr;
162:108127.
PMID: 32224163
SGLT-2 inhibitors are known to increase hematocrit. We present two cases with marked asymptomatic erythrocytosis developing after taking SGLT-2 inhibitors. No other predisposing or causative factor was found and SGLT-2...
20.
Jha A, Misra A, Gupta R, Ghosh A, Tyagi K, Dutta K, et al.
Diabetes Metab Syndr
. 2020 Mar;
14(3):213-216.
PMID: 32172176
Background: Dipeptidyl peptidase 4 (DPP4) inhibitors have increasingly been linked to bullous pemphigoid, but there is paucity of data from India where about 1.85 million patients have been estimated to...